Olympus expands in cancer tech with $270M buy of BioProtect

Olympus said Tuesday it has agreed to buy Israel-based BioProtect for $270 million to expand its product portfolio in ...
Medindia

BioProtect Announces Final Closing of Equity Financing at $25M To Protect Prostate Cancer Patients

TZUR YIGAL, Israel, Sept. 21, 2020 /PRNewswire/ -- BioProtect ltd., a private company with a unique bioabsorbable polymer spacer balloon platform, announced the final closing of $25 million of its ...
Yahoo Finance

Olympus agrees $270m BioProtect buyout to expand prostate cancer offerings

Olympus has agreed to acquire BioProtect in a $270m deal, giving the company a commercial device that will help expand its prostate cancer care provision. Israel-based BioProtect’s lead product is ...
Medindia

BioProtect receives FDA's clearance for its biodegradable balloon for rectal protection during prostate cancer radiation therapy

TZUR YIGAL, Israel, Aug. 28, 2023 /PRNewswire/ -- Israeli medical devices manufacturer BioProtect Ltd. announced today that their BioProtect Balloon Implant ™ System has been cleared by the FDA. The ...
Morningstar

Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer

TOKYO, May 26, 2026 /PRNewswire/ -- Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, announced today it has signed a definitive agreement to ...
dailyfreeman.com

BioProtect Notes Completion of Patient Enrollment for its IDE Pivotal Study of the ProSpaceTM Balloon Spacer

TZUR IGAL, Israel, June 15, 2021 /PRNewswire/ — BioProtect Ltd., a private commercial-stage medical device company, announced today that the company has enrolled all the planned patients in the ...
MD&M East

BioProtect Nabs $28M for Balloon Implant System Commercialization

BioProtect, a company providing biodegradable spacing solutions, recently announced it closed its most recent funding round with $28 million from investors. The round was led by MVM Partners, with ...
Mena FN

Olympus To Acquire Bioprotect To Expand Its Portfolio Of Urological Technologies And Address Prostate Cancer

BioProtect develops implant technologies that contribute to improving prostate cancer care and enhancing patients' quality of life. Its flagship Balloon Spacer system is designed to provide consistent ...